Intravitreous bevacizumab to treat subfoveal choroidal neovascularization in highly myopic eyes: short-term results

Aim To describe the anatomical and visual outcome of subfoveal and juxtafoveal choroidal neovascularization (CNV) in highly myopic eyes treated by intravitreal bevacizumab. Methods Prospective, nonrandomized, multicentric, interventional pilot study. Twenty-six highly myopic eyes from 25 patients wi...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Eye (London) 2009-02, Vol.23 (2), p.334-338
Hauptverfasser:	Ruiz-Moreno, J M, Gomez-Ulla, F, Montero, J A, Ares, S, Lopez-Lopez, F, Rodriguez, M, Fernandez, M
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Aged, 80 and over Angiogenesis Inhibitors - administration & dosage Angiogenesis Inhibitors - therapeutic use Antibodies, Monoclonal - administration & dosage Antibodies, Monoclonal - therapeutic use Antibodies, Monoclonal, Humanized Bevacizumab Biological and medical sciences Choroidal Neovascularization - drug therapy Choroidal Neovascularization - etiology Choroidal Neovascularization - physiopathology clinical-study Female Humans Injections, Intraocular Laboratory Medicine Male Medical sciences Medicine Medicine & Public Health Middle Aged Miscellaneous Myopia, Degenerative - complications Myopia, Degenerative - physiopathology Ophthalmology Pharmaceutical Sciences/Technology Pilot Projects Prospective Studies Surgery Surgical Oncology Treatment Outcome Vision disorders Visual Acuity Vitreous Body
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!